| Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 11.50M | 9.24M | 16.35M | 8.16M | 7.19M | 5.40M |
| Gross Profit | 1.60M | 1.67M | 4.00K | 2.23M | 2.33M | 1.73M |
| EBITDA | -15.92M | 537.00K | -1.99M | -481.00K | 1.55M | -1.22M |
| Net Income | -16.46M | -16.81M | -3.84M | -2.04M | -259.00K | -2.17M |
Balance Sheet | ||||||
| Total Assets | 64.80M | 67.43M | 87.34M | 96.05M | 89.33M | 80.26M |
| Cash, Cash Equivalents and Short-Term Investments | 263.00K | 1.03M | 782.00K | 1.09M | 970.00K | 928.00K |
| Total Debt | 26.32M | 27.84M | 25.59M | 30.35M | 25.38M | 27.80M |
| Total Liabilities | 29.53M | 32.32M | 33.25M | 39.98M | 33.12M | 33.11M |
| Stockholders Equity | 34.63M | 35.10M | 54.09M | 56.07M | 56.21M | 47.15M |
Cash Flow | ||||||
| Free Cash Flow | -1.86M | -1.21M | 4.28M | -3.76M | -1.17M | -3.45M |
| Operating Cash Flow | -1.60M | -874.00K | 4.55M | -3.67M | -974.00K | -3.29M |
| Investing Cash Flow | 3.72M | 947.00K | -261.00K | -1.03M | 14.00K | -171.00K |
| Financing Cash Flow | -2.43M | 179.00K | -4.60M | 4.82M | 1.00M | 3.60M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Neutral | £45.55M | 10.36 | 11.64% | 7.35% | -25.56% | -42.49% | |
64 Neutral | £75.43M | 85.60 | 4.94% | 2.25% | -15.64% | -22.46% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
57 Neutral | £38.41M | 2,272.39 | 0.90% | 3.29% | -6.46% | -56.20% | |
49 Neutral | £60.70M | 1.20 | 28.14% | ― | ― | ― | |
40 Underperform | £1.60M | -0.05 | -52.46% | ― | 11.78% | -39.58% | |
38 Underperform | £5.00M | -4.15 | -37.69% | ― | -29.25% | -262.26% |